Cited by 74AI in cancer detectionArtificial Intelligence in Healthcare and EducationRadiomics and Machine Learning in Medical Imaging

Artificial Intelligence Advancements in Oncology: A Review of Current Trends and Future Directions

Open access
Huhulea, Ellen N., Huang, Lillian, Eng, Shirley, Sumawi, Bushra, Huang, Audrey, Aifuwa, Esewi, Hirani, Rahim, Tiwari, Raj K. +1 more·2025·Biomedicines

Abstract

Cancer remains one of the leading causes of mortality worldwide, driving the need for innovative approaches in research and treatment. Artificial intelligence (AI) has emerged as a powerful tool in oncology, with the potential to revolutionize cancer diagnosis, treatment, and management. This paper reviews recent advancements in AI applications within cancer research, focusing on early detection through computer-aided diagnosis, personalized treatment strategies, and drug discovery. We survey AI-enhanced diagnostic applications and explore AI techniques such as deep learning, as well as the integration of AI with nanomedicine and immunotherapy for cancer care. Comparative analyses of AI-based models versus traditional diagnostic methods are presented, highlighting AI’s superior potential. Additionally, we discuss the importance of integrating social determinants of health to optimize cancer care. Despite these advancements, challenges such as data quality, algorithmic biases, and clinical validation remain, limiting widespread adoption. The review concludes with a discussion of the future directions of AI in oncology, emphasizing its potential to reshape cancer care by enhancing diagnosis, personalizing treatments and targeted therapies, and ultimately improving patient outcomes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biomedicines13040951

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AI-enabled digital health tools are maturing rapidly.

    “AI-enabled digital health tools are maturing rapidly and can serve to supplement care access where there are fewer providers physically available, particularly in under-resourced regions.3”

    From Empathic and agentic artificial intelligence in nursing: perspectives on a human-centered framework for cancer care navigation in the United States of America (2026) · cites this paper as [3]

    The Introduction and Conclusions describe rapid advances in oncology AI and its potential to expand access to cancer care. Section 6 also discusses healthcare disparities. None of these passages addresses supplementing care where providers are physically scarce, particularly in under-resourced regions; the paper’s support is narrower than the full citing sentence. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • AI-enabled digital health tools can serve to supplement care access where there are fewer providers physically available, particularly in under-resourced regions.

    “AI-enabled digital health tools are maturing rapidly and can serve to supplement care access where there are fewer providers physically available, particularly in under-resourced regions.3”

    From Empathic and agentic artificial intelligence in nursing: perspectives on a human-centered framework for cancer care navigation in the United States of America (2026) · cites this paper as [3]

    The Introduction says AI diagnostic tools can expand access to pathology and radiology interpretation, and Section 2 describes their improving performance and role as aids to clinicians. The paper does not specifically say that digital health tools supplement care where providers are physically scarce, particularly in under-resourced regions; the claim extends its oncology-diagnostics discussion to a broader setting. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Generative AI systems can summarize studies, identify key themes, and surface relevant literature more efficiently than manual review.

    “Generative AI (GenAI) systems can summarize studies, identify key themes, and surface relevant literature more efficiently than manual review.8,9”

    From Artificial Intelligence in Oncology: Practical Applications Across Clinical Care, Scholarship, and Translation. (2026) · cites this paper as [9]

    The Introduction to AI in Cancer Research and §6.2, Harvesting Unstructured Data Potential (page numbers unavailable), discuss AI pattern recognition and extracting information from clinical notes, not reviewing research literature. Searches for generative AI, study summarization, literature reviews, and comparisons with manual review found no passage addressing the attributed claim. (LLM, conf=0.74)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Huhulea, E. N., Huang, L., Eng, S., Sumawi, B., Huang, A., Aifuwa, E., Hirani, R., Tiwari, R. K., & Etienne, M.
Affiliations
  • New York Medical College (US)
  • The University of Texas at San Antonio Health Science Center (US)
Corresponding author
Etienne, Mill
Venue
Biomedicines
Publisher
MDPI AG
Published
2025-04-13
Volume
13
Issue
4
Pages
951
ISSN
2227-9059 (ISSN-L)
OpenAlex
W4409456828
Cited by
74
References
135
Citations by year
2026: 52 · 2025: 22
FWCI
7.10
Type
journal article
Language
en
Open access
Locations
  • Biomedicines (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Touro Scholar (Touro College) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
Keywords
artificial intelligence in oncology, cancer diagnosis, computer-aided diagnosis, early cancer detection, precision oncology, anticancer drug discovery, deep learning, nanomedicine, immunotherapy, social determinants of health, algorithmic bias, clinical validation, data quality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review